Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival
Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of mortality after TAVI. Methods Three-centre prospective observational study including 358 patients. Endpoints were defined according to the Valve...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2012
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/21871
- Acceso en línea:
- https://doi.org/10.1007/s12471-011-0224-z
https://repository.urosario.edu.co/handle/10336/21871
- Palabra clave:
- Promoción de salud
Enfermedades
Aortic stenosis
Transcatheter aortic valve implantation
Surgical aortic valve replacement
Treatment decision
Complications
Prognosis
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_173095a0557cfaff50f832204705828c |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/21871 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
title |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
spellingShingle |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival Promoción de salud Enfermedades Aortic stenosis Transcatheter aortic valve implantation Surgical aortic valve replacement Treatment decision Complications Prognosis |
title_short |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
title_full |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
title_fullStr |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
title_full_unstemmed |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
title_sort |
Patients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survival |
dc.subject.ddc.spa.fl_str_mv |
Promoción de salud Enfermedades |
topic |
Promoción de salud Enfermedades Aortic stenosis Transcatheter aortic valve implantation Surgical aortic valve replacement Treatment decision Complications Prognosis |
dc.subject.keyword.spa.fl_str_mv |
Aortic stenosis Transcatheter aortic valve implantation Surgical aortic valve replacement Treatment decision Complications Prognosis |
description |
Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of mortality after TAVI. Methods Three-centre prospective observational study including 358 patients. Endpoints were defined according to the Valve Academic Research Consortium. Results Of the 358 patients referred for TAVI, TAVI was performed in 235 patients (65%), surgical aortic valve replacement (AVR) in 24 (7%) and medical therapy (MT) in 99 (28%). Reasons to decline TAVI in favour of AVR/MT were patient preference (29%), peripheral vascular disease (15%) and non-severe aortic stenosis (11%). The logistic EuroSCORE was significantly higher in patients who underwent TAVI and MT in comparison with those undergoing AVR (19 vs. 10%, p=0.007). At 30 days, all-cause mortality and the combined safety endpoint were 9 and 24% after TAVI and 8 and 25% after AVR, respectively. All-cause mortality was significantly lower in the TAVI group compared with the MT group at 6 months, 1 year and 2 years (12% vs. 22%, 21% vs. 33% and 31% vs. 55%, respectively, p<0.001). Multivariable analysis revealed that blood transfusion (HR: 1.19; 95% CI: 1.05-1.33), pre-existing renal failure (HR: 1.18; 95% CI: 1.06-1.33) and STS score (HR: 1.06; 95% CI: 1.02-1.10) were independent predictors of mortality at a median of 10 (IQR: 3-23) months after TAVI. Conclusions Approximately two-thirds of the patients referred for TAVI receive this treatment with gratifying short- and long-term survival. Another 7% underwent AVR. Prognosis is poor in patients who do not receive valve replacement therapy. © The Author(s) 2011. |
publishDate |
2012 |
dc.date.created.none.fl_str_mv |
2012 |
dc.date.issued.none.fl_str_mv |
2012 |
dc.date.accessioned.none.fl_str_mv |
2020-05-05T23:23:16Z |
dc.date.available.none.fl_str_mv |
2020-05-05T23:23:16Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1007/s12471-011-0224-z |
dc.identifier.issn.none.fl_str_mv |
1568-5888 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/21871 |
url |
https://doi.org/10.1007/s12471-011-0224-z https://repository.urosario.edu.co/handle/10336/21871 |
identifier_str_mv |
1568-5888 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
23 |
dc.relation.citationIssue.none.fl_str_mv |
No. 1 |
dc.relation.citationStartPage.none.fl_str_mv |
16 |
dc.relation.citationTitle.none.fl_str_mv |
Netherlands Heart Journal |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 20 |
dc.relation.ispartof.spa.fl_str_mv |
Netherlands Heart Journal, ISSN: 1568-5888 Vol. 20, No. 1 (2012) pp. 16-23 |
dc.relation.uri.spa.fl_str_mv |
https://link.springer.com/content/pdf/10.1007%2Fs12471-011-0224-z.pdf |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
institution |
Universidad del Rosario |
dc.source.instname.none.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.none.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/e0b44812-e52e-4ec6-977a-1d6c7ae2b025/download https://repository.urosario.edu.co/bitstreams/2e396eb7-79c4-4031-9a32-d7f187d6b90b/download https://repository.urosario.edu.co/bitstreams/69830887-31d1-498a-85a9-010bed6cf874/download |
bitstream.checksum.fl_str_mv |
8e6a708549d31afa4e4bb84fe4613275 30024f9353725fa0e0dafc5f7154c3ee fdb2e06f72ab45ba67535269ce9ecf59 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167659119378432 |
spelling |
9b8e1aeb-fa42-44f8-ab35-723d3f4f78bf-18cd9a000-2454-4448-b704-490b681e5ed2-1b1f7fbd8-0182-416e-a574-bbf27625764c-13afe603d-fcf1-4613-b039-2f0890796472-1dba6e67b-6bfd-4d66-b9d5-9abd825e744a-1b9080818-6724-4bd2-85cc-01548051db0b-181fcb6d3-f076-4c8f-9ac1-8bafe6f76b25-11a019a60-a808-4f33-887b-43d109da4f47-1ef596336-4bbd-4dd0-b401-c365079c050a-109e4fc58-75f0-490b-897b-b941449c1eee-19a7bc159-2032-44b8-9c6b-276d40bb3ed4-11435df54-e507-4802-a066-3ffd57279725-12020-05-05T23:23:16Z2020-05-05T23:23:16Z20122012Aims To assess treatment decision and outcome in patients referred for transcatheter aortic valve implantation (TAVI) in addition to predictive factors of mortality after TAVI. Methods Three-centre prospective observational study including 358 patients. Endpoints were defined according to the Valve Academic Research Consortium. Results Of the 358 patients referred for TAVI, TAVI was performed in 235 patients (65%), surgical aortic valve replacement (AVR) in 24 (7%) and medical therapy (MT) in 99 (28%). Reasons to decline TAVI in favour of AVR/MT were patient preference (29%), peripheral vascular disease (15%) and non-severe aortic stenosis (11%). The logistic EuroSCORE was significantly higher in patients who underwent TAVI and MT in comparison with those undergoing AVR (19 vs. 10%, p=0.007). At 30 days, all-cause mortality and the combined safety endpoint were 9 and 24% after TAVI and 8 and 25% after AVR, respectively. All-cause mortality was significantly lower in the TAVI group compared with the MT group at 6 months, 1 year and 2 years (12% vs. 22%, 21% vs. 33% and 31% vs. 55%, respectively, p<0.001). Multivariable analysis revealed that blood transfusion (HR: 1.19; 95% CI: 1.05-1.33), pre-existing renal failure (HR: 1.18; 95% CI: 1.06-1.33) and STS score (HR: 1.06; 95% CI: 1.02-1.10) were independent predictors of mortality at a median of 10 (IQR: 3-23) months after TAVI. Conclusions Approximately two-thirds of the patients referred for TAVI receive this treatment with gratifying short- and long-term survival. Another 7% underwent AVR. Prognosis is poor in patients who do not receive valve replacement therapy. © The Author(s) 2011.application/pdfhttps://doi.org/10.1007/s12471-011-0224-z1568-5888https://repository.urosario.edu.co/handle/10336/21871eng23No. 116Netherlands Heart JournalVol. 20Netherlands Heart Journal, ISSN: 1568-5888 Vol. 20, No. 1 (2012) pp. 16-23https://link.springer.com/content/pdf/10.1007%2Fs12471-011-0224-z.pdfAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPromoción de salud613600Enfermedades616600Aortic stenosisTranscatheter aortic valve implantationSurgical aortic valve replacementTreatment decisionComplicationsPrognosisPatients with aortic stenosis referred for TAVI : Treatment decision, in-hospital outcome and determinants of survivalarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Nuis, R.J.Dager, A.E.Van der Boon, R.M.Jaimes, M.C.Caicedo, B.Fonseca, J.Van Mieghem, N.M.Benitez, L.M.Umana, J.P.O'Neill, W.W.de Marchena, E.de Jaegere, P.P.Nuis, R.J.Dager, A.E.Van der Boon, R.M.Jaimes, M.C.Caicedo, B.Fonseca, J.Van Mieghem, N.M.Benitez, L.M.Umana, J.P.O'Neill, W.W.de Marchena, E.de Jaegere, P.P.ORIGINALPatients_with_aortic_stenosis_referred_for_TAVI.pdfapplication/pdf241720https://repository.urosario.edu.co/bitstreams/e0b44812-e52e-4ec6-977a-1d6c7ae2b025/download8e6a708549d31afa4e4bb84fe4613275MD51TEXTPatients_with_aortic_stenosis_referred_for_TAVI.pdf.txtPatients_with_aortic_stenosis_referred_for_TAVI.pdf.txtExtracted texttext/plain29790https://repository.urosario.edu.co/bitstreams/2e396eb7-79c4-4031-9a32-d7f187d6b90b/download30024f9353725fa0e0dafc5f7154c3eeMD52THUMBNAILPatients_with_aortic_stenosis_referred_for_TAVI.pdf.jpgPatients_with_aortic_stenosis_referred_for_TAVI.pdf.jpgGenerated Thumbnailimage/jpeg4533https://repository.urosario.edu.co/bitstreams/69830887-31d1-498a-85a9-010bed6cf874/downloadfdb2e06f72ab45ba67535269ce9ecf59MD5310336/21871oai:repository.urosario.edu.co:10336/218712021-06-03 00:49:20.598https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |